- Mohammad Bagher Tabatabaei
 - - Department of Cardiovascular Surgery, Shahid Rajaee Hospital, Faculty of Medicine, Iran University , Tehran, Iran
- Fahimeh Kashfi
- - Shahid Rajaee Hospital, Tehran, Iran
- Amir Jamshid Khamoshi
- - Department of Cardiovascular Surgery, Shahid Rajaee Hospital, Faculty of Medicine, Iran University , Tehran, Iran
- Saeed Hosseini
- - Department of Cardiovascular Surgery, Shahid Rajaee Hospital, Faculty of Medicine, Iran University , Tehran, Iran
- Majid Maleki
- - Department of Cardiology, Shahid Rajaee Hospital, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
- Fereydoun Noohi
- - Department of Cardiology, Shahid Rajaee Hospital, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
Received: 10/1/2003 Accepted: 10/1/2003 - Publisher : Avicenna Research Institute |
| Related Articles |
|
| Other Format |
|
|
|
Abstract
There is a risk of thromboembolic complications in patients with prosthetic heart valves, to reduce this risk, anticoagulant drugs should be used. Besides thromboembolic events in pregnant women with prosthetic heart valves, anticoagulants may cause embryopathy, abortion, C.V.A. and valve thrombosis in mothers with generally high mortality. So, this study was performed to determine the pregnancy outcome in patients with prosthetic heart valves in Shahid Rajaee Heart Hospital. Eighty women aged 12-45 years old who underwent heart valve replacement at this hospital between 1978 and 1998 were included in this study. In these patients who had warfarin therapy during the whole period of pregnancy, 144 pregnancy and 18 elective abortion was occurred. Mitral Valve Replacement (MVR) was performed in 58.7%, Aortic Valve Replacement (AVR) in 16.3% and MVR plus AVR in 25%.Generally, 89.68% of the pregnancies were without any complications for mothers, but 5.56% of them had complications such as C.V.A., hypertention, edema, dyspnea and prosthetic valve malfunction. Mother death occurred in 4.76% of them. There were 38.09% normal birth with healthy baby, 50% abortion, 3.18% congenital deformities and 8.73% infant death following premature delivery, still birth and maternal death during pregnancy. Our findings showed that fetal and maternal complications in women with prosthetic heart valve using anticoagulant drugs were more common in comparison with the normal population and suggests the more clear and complete assesments in this respect. Although most pregnancy losses in women with prosthetic valve were due to warfarin use, in cases the dose of warfarin is less than 5mg/day, shifting to heparin is not recommended because a low dose of warfarin has low maternal and fetal risks.
Keywords:
Pregnancy, Mechanical heart valve, Abortion, Maternal complications, Fetal complications To cite this article:References
- Roodpeyma S.H. Rheumatic fever in Iranian children.Med J I.R.I.1995;9(3):179-182.
- Bloomfield P. Choice of heart valve prosthesis. Heart.2002;87:583-589.
- Cunningham F., Macdonald P., Gant N., et al. Williams Obstetrics. 20th Edition, Prentice Hall. 1997;pp:1088-1092.
- Braunwald E. Heart disease, a textbook of Cardiovascular Medicine. Vol(1), 6 th Edition, W.B. Saunders, U.S.A. 2001;pp:2172-2186.
- Hanania G. Management of anticoagulations during pregnancy.Heart.2001;86:125-126.
- Bonow R.O., Curobelo B., Deleon A.C., et al. ACC/AHA Guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol.1998;32:1486-1588.
- Elkayam U. Pregnancy through a prosthetic heart valve. J Am Coll Cardiol.1999;33:1642-1645.
- Hanania G., Thomas D., Michel P.L., et al. Grossesses chez les porteuses de prostheses valvulaires: etude cooperative retrospective francaise (155 case). Arch Mal Coeur.1994; 87:429-437.
- Hung L., Rahimtoola., ShH. Prosthetic heart valves and pregnancy. Circulation.2003;107:1240.
- Sbarouni E., Oakley C.M. Outcome of pregnancy in women with valve prostheses. Br Heart J.1994;71:196-201.
- Elkayam U., Khan S.S. Pregnancy in the patient with artificial heart valve. Cardiac problems in pregnancy. 3 th Edition, New York, Wiley-Liss, 1998;pp:61-78.
- Vitale N., Defeo M., De Santo L.S., et al. Dose–dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J AM Coll Cardiol.1999;33:1637-1641.
- Hall J.G., Pauli R.M., Wilson K.M. Maternal and fetal sequelae and anticoagulation during pregnancy. Am J Med.1980;68:122-140.
- Lee L.H., Liavw P.C.Y., Ng A.S.H. LMWH for thromboprophylaxis during pregnancy in two patients with mechanical heart valve replacement. Thromb Haemost.1996;76:627-31.
- AL-Lawati A.M., Venkitraman M., AL–Delaime T., et al. Pregnancy and mechanical heart valves replacement: dilemma of anti coagulation. Eur J Cardiothorac Surg.2002; 22:223-227.
- Sadler L., Mccowan L., White H., et al. Pregnancy outcomes and cardiac complications in women with mechanical, bioprostetic and homograft valves. BJOG.2000;10(2):245-253.
- Vitale N., Defeo M., Cotrufo M.Anticoagulation for prosthetic heart valves during pregnancy:The importance of warfarin daily dose. Eur J Cardio Thorac Surg 2002;22:656-657.